Gene therapy - Is IL2RG oncogenic in T-cell development?

Karin Overzet; D (Dirk) de Ridder; F (Floor) Weerkamp; Miranda Baert; Monique Verstegen; MH (Martijn) Brugman; SJ Howe; MJT Reinders; AJ Thrasher; Gerard Wagemaker; Jacques Dongen; Frank Staal

doi:10.1038/nature05218

Gene therapy - Is IL2RG oncogenic in T-cell development?

Karin Overzet, D (Dirk) de Ridder, F (Floor) Weerkamp, Miranda Baert, Monique Verstegen, MH (Martijn) Brugman, SJ Howe, MJT Reinders, AJ Thrasher, Gerard Wagemaker, Jacques Dongen, Frank Staal

Research output: Contribution to journal › Article › Academic › peer-review

58 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	E5-E5
Journal	Nature
Volume	443
Issue number	7109
DOIs	https://doi.org/10.1038/nature05218
Publication status	Published - 2006

Research programs

EMC MM-02-41-04
EMC MM-02-72-01

Access to Document

10.1038/nature05218

http://hdl.handle.net/1765/53876

Cite this

@article{952722c9f92c4021b21217908f4157b5,

title = "Gene therapy - Is IL2RG oncogenic in T-cell development?",

author = "Karin Overzet and {de Ridder}, {D (Dirk)} and Weerkamp, {F (Floor)} and Miranda Baert and Monique Verstegen and Brugman, {MH (Martijn)} and SJ Howe and MJT Reinders and AJ Thrasher and Gerard Wagemaker and Jacques Dongen and Frank Staal",

year = "2006",

doi = "10.1038/nature05218",

language = "Undefined/Unknown",

volume = "443",

pages = "E5--E5",

journal = "Nature",

issn = "0028-0836",